Company intelligence / Profile preview

Institut AllergoSan

Graz, Styria, Austriaallergosan.com ↗
Ownership
Private
Employees
~216
Development stage
Commercial
01

Overview

Institut AllergoSan has over three decades of experience in developing evidence-based probiotics and natural supplements. Its flagship brand OMNi-BiOTiC® has become one of the top global probiotic brands—ranked #3 worldwide as of recent years—and its products are available in over forty countries. The company collaborates with international researchers to develop multi-strain probiotics for specific medical indications such as antibiotic-associated diarrhea, metabolic syndrome/type II diabetes risk factors, stress-induced gut dysfunctions, and more. Clinical results have been published in peer-reviewed journals supporting efficacy for several indications.

Therapeutic areas
GastroenterologyDermatologyMetabolic Disorders
Modalities
Probiotics (multi-strain and indication-specific)Plant extracts and mineralsOrthomolecular medicine
Industry
Non-Drug Biotech
02

Drug pipeline

3 assets

OMNi-BiOTiC

Commercial
Indications
Gut health, Immune support

2 more assets in the full pipeline.

Request access →
03

Partnerships

Zuellig Pharma – exclusive ten-year commercialization partnership for Asia-Pacific region to distribute OMNi-BiOTiC® products.

Beyond the preview

Go deeper on Institut AllergoSan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Institut AllergoSan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call